Search - tctmd.com

Displaying 381 - 400 of 488

Sort: Relevancy | Date

News Daily News

Novel TEVAR System for Complicated Aortic Dissection Shows Promise

Yael L. Maxwell

February 26, 2014

News Daily News

Over the Long Haul, TAVR Appears Better Than Surgery for Women

Caitlin E. Cox

February 19, 2014

News Industry News

Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections

January 27, 2014

News Industry News

Edwards to Begin U.S. Trial of SAPIEN 3 Valve for Intermediate Risk Patients

January 12, 2014

News Daily News

EVAR Reduces Short-, Long-term Mortality vs. Surgery for Ruptured AAA

December 30, 2013

News Daily News

Comparada con la Cirugía, EVAR Reduce la Mortalidad a Corto y Largo Plazo en el Manejo de Roturas de AAA

December 30, 2013

News Daily News

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

December 02, 2013

News Daily News

Grupos Subrayan Cuestiones Importantes para Divulgar las Terapias Transcatéter de la Válvula Mitral

December 02, 2013

News Industry News

Valiant 'Mona LSA' Stent Graft System from Medtronic Demonstrates Proof of Concept in Early Feasibility Study

November 19, 2013

News Conference News AHA 2013

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Jason Kahn

November 16, 2013

News Industry News

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

October 31, 2013

Presentation TCT 2013

Case Presentation: A Complex Thoracic Aortic Case

Presenter: Wilson Szeto

October 30, 2013

Presentation TCT 2013

TEVAR Treatment of Blunt Thoracic Aortic Injury: Current Techniques and Results

Presenter: Rodney White

October 30, 2013

Presentation TCT 2013

Case #1: Hybrid Repair of a Thoracic Aorta Aneurysm (Two Years after Bental Procedure)

Presenter: Sergey Abugov

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

News Industry News

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

October 29, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

Advertisement

Novel TEVAR System for Complicated Aortic Dissection Shows Promise

Over the Long Haul, TAVR Appears Better Than Surgery for Women

Valiant Captivia Thoracic Stent Graft System From Medtronic Receives FDA Approval for Treating Aortic Dissections

Edwards to Begin U.S. Trial of SAPIEN 3 Valve for Intermediate Risk Patients

EVAR Reduces Short-, Long-term Mortality vs. Surgery for Ruptured AAA

Comparada con la Cirugía, EVAR Reduce la Mortalidad a Corto y Largo Plazo en el Manejo de Roturas de AAA

Groups Outline Key Issues for Dissemination of Transcatheter Mitral Valve Therapies

Grupos Subrayan Cuestiones Importantes para Divulgar las Terapias Transcatéter de la Válvula Mitral

Valiant 'Mona LSA' Stent Graft System from Medtronic Demonstrates Proof of Concept in Early Feasibility Study

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

Case Presentation: A Complex Thoracic Aortic Case

TEVAR Treatment of Blunt Thoracic Aortic Injury: Current Techniques and Results

Case #1: Hybrid Repair of a Thoracic Aorta Aneurysm (Two Years after Bental Procedure)

Two Trials to Assess TAVR in Moderate-Risk Patients

Opportunities Exist to Improve Outcomes in Transapical TAVR

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content